Contact

Mailing Address

One Kendall Square, Suite B7201
Cambridge, MA 02139
Phone: 617-441-1000
Fax: 617-491-1386

For Media and Investor Inquiries:

Media Contact:
Kathleen Gallagher
617-441-1043
Email: kgallagher@merrimackpharma.com

Investor Contact:
Geoffrey Grande, CFA
617-441-7602
Email: ggrande@merrimackpharma.com

For doctors or healthcare providers seeking information about Merrimack's investigational products:

U.S. Medical Information Contact:
844-441-MACK
(844-441-6225)
Email: MerrimackMedInfo@quintiles.com

For healthcare providers seeking information about Merrimack’s support for the single-patient expanded access program (EAP) for MM-398 (irinotecan liposome injection), please contact Idis, the EAP program administrator:

EAP Contact:
877-768-4303
 
Only physicians can enroll patients in an EAP. Patients should work through their physician to determine eligibility.
 

For business development or general corporate inquiries, please email us using the form below: